Takeda: Clinical Trials & Research Profile

Biopharma Industry (Tokyo, JP / Cambridge, MA) · Primary Focus: Rare Genetic, Women's Health, and Other

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Tokyo, JP / Cambridge, MA)
Primary Therapeutic AreaRare Genetic, Women's Health, and Other
Active Phase II & III Studies63 active (43 recruiting now)
Total Tracked Studies (2018 to 2026)192 (104 with California sites)
Completed vs Early-Stopped Studies95 completed / 34 stopped (17.7% stop rate)
Median Closed Enrollment56 participants
FDA Drugs@FDA Original Approvals63 all-time (9 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Takeda across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk